Laura Soldati Selected Research

Calcium-Sensing Receptors

1/2018	High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.
1/2017	Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
2/2015	Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.
9/2013	Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis.
1/2013	Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient.
7/2012	Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis.
5/2012	A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
11/2011	Calcium-sensing receptor and calcium kidney stones.
3/2011	Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism.
7/2010	Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Soldati Research Topics

Disease

12	Nephrolithiasis 02/2015 - 05/2008
8	Kidney Calculi (Kidney Stone) 02/2015 - 03/2002
6	Hypercalciuria 01/2017 - 10/2002
4	Neoplasms (Cancer) 01/2018 - 01/2015
3	Inflammation (Inflammations) 01/2022 - 01/2016
3	Chronic Renal Insufficiency 01/2022 - 07/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 01/2015
3	Hyperparathyroidism 01/2018 - 07/2011
3	Obesity 11/2017 - 11/2014
3	Osteoporosis 05/2008 - 12/2003
2	COVID-19 11/2020 - 01/2020
2	Insulin Resistance 08/2019 - 04/2015
2	Type 2 Diabetes Mellitus (MODY) 08/2019 - 11/2017
2	Primary Hyperparathyroidism 01/2017 - 02/2015
2	Hypocalcemia 01/2017 - 01/2013
2	Nephrocalcinosis 01/2017 - 04/2008
2	Bartter Syndrome (Syndrome, Bartter) 01/2013 - 07/2006
2	Hypercalcemia (Milk Alkali Syndrome) 05/2012 - 04/2009
1	Noncommunicable Diseases 01/2022
1	Weight Gain 01/2020
1	Celiac Disease (Celiac Sprue) 01/2020
1	Weight Loss (Weight Reduction) 11/2017
1	Hyperphosphatemia 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Atherosclerosis 01/2016
1	Triple Negative Breast Neoplasms 11/2015
1	Neoplasm Metastasis (Metastasis) 11/2015
1	Residual Neoplasm 11/2015
1	Ovarian Neoplasms (Ovarian Cancer) 11/2015
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Non-alcoholic Fatty Liver Disease 04/2015
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2015
1	Overweight 02/2014
1	type 1 familial Hypocalciuric hypercalcemia 05/2012
1	Hypophosphatemia 05/2012
1	Disease Progression 03/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2011
1	Alkalosis 07/2006
1	Hypokalemia 07/2006

Drug/Important Bio-Agent (IBA)

20	CalciumIBA 01/2017 - 03/2002
15	Calcium-Sensing ReceptorsIBA 01/2018 - 10/2002
4	Parathyroid Hormone (Parathormone)IBA 01/2017 - 05/2012
4	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2008 - 03/2002
3	SodiumIBA 05/2013 - 04/2009
3	Adenylyl Cyclases (Adenylyl Cyclase)IBA 05/2008 - 04/2008
2	CurcuminIBA 01/2022 - 08/2019
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2002
2	LipidsIBA 01/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2014
2	Citric Acid (Citrate)FDA LinkGeneric 05/2013 - 07/2012
2	PotassiumIBA 04/2009 - 07/2006
2	claudin 16IBA 05/2008 - 04/2008
2	sodium phosphate (trisodium phosphate)FDA LinkGeneric 05/2008 - 04/2008
1	EndotoxinsIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Sarcoglycans (beta Sarcoglycan)IBA 08/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2020
1	Glutens (Glutelin)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2018
1	FilaminsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2016
1	PolyphenolsIBA 01/2016
1	GlycolipidsIBA 11/2015
1	EnzymesIBA 11/2015
1	stage-specific embryonic antigen-4IBA 11/2015
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	MicroRNAs (MicroRNA)IBA 11/2015
1	Docosahexaenoic AcidsIBA 04/2015
1	Cinacalcet (Sensipar)FDA Link 01/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 11/2014
1	Triglycerides (Triacylglycerol)IBA 02/2014
1	claudin 14IBA 09/2011
1	Biological ProductsIBA 07/2011
1	Calcium OxalateIBA 03/2010
1	Bicarbonates (Hydrogen Carbonate)IBA 05/2008
1	ChloridesIBA 05/2008
1	Mixed Function Oxygenases (Monooxygenases)IBA 04/2008
1	CLC-5 chloride channelIBA 04/2008
1	ReninIBA 07/2006
1	AldosteroneIBA 07/2006
1	Initiator Codon (Start Codon)IBA 03/2002

Therapy/Procedure

6	Therapeutics 11/2020 - 03/2010
3	Mediterranean Diet 01/2022 - 02/2014
1	Renal Dialysis (Hemodialysis) 08/2020
1	Gluten-Free Diet 01/2020
1	Ketogenic Diet 01/2018
1	Immunotherapy 01/2018
1	Chronotherapy 11/2017
1	Bariatric Surgery 01/2016
1	Drug Therapy (Chemotherapy) 11/2015
1	Neoadjuvant Therapy 11/2015
1	Secondary Prevention 05/2013
1	Parathyroidectomy 05/2012
1	Conservative Treatment 07/2011
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 03/2010